Notice2024-22477
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 1, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Breast and Cervical Cancer Early Detection Program (NBCCEDP) Monitoring Activities. This data collection is designed to systematically collect information about implementation, including delivery of screening and follow-up clinical services, and outcomes of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 190 (Tuesday, October 1, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 190 (Tuesday, October 1, 2024)]
[Notices]
[Pages 79922-79923]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-22477]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-1046; Docket No. CDC-2024-0074]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) Monitoring Activities. This data collection is designed to
systematically collect information about implementation, including
delivery of screening and follow-up clinical services, and outcomes of
the National Breast and Cervical Cancer Early Detection Program
(NBCCEDP).
DATES: CDC must receive written comments on or before December 2, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0074 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#0d62606f4d6e696e236a627b"><span class="__cf_email__" data-cfemail="aec1c3cceecdcacd80c9c1d8">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) Monitoring Activities (OMB Control No. 0920-1046, Exp. 03/31/
2025)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a Revision of the information collection titled
National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
Monitoring Activities (OMB Control No. 0920-1046). The information
collection consists of an annual NBCCEDP survey, baseline and annual
clinic-level data collection, a quarterly program update (QPU) tool, a
service delivery projection worksheet, and minimum data elements
(MDEs). CDC proposes revisions to the Annual NBCCEDP Survey, clinic-
level data collection tool and QPU, and continued use of the service
delivery projection worksheet and MDEs with no changes. The number of
respondents will increase from 70 to 71 and the total estimated
annualized burden will decrease from 1,220 hours to 1,162 hours.
Breast and cervical cancers are prevalent among U.S. women. In
2021, the U.S. experienced 272,454 new cases and 42,211 deaths as a
result of breast cancer, as well as 12,536 new cases and 4,051 deaths
as a result of cervical cancer. Evidence shows that deaths from both
breast and cervical cancers can be avoided by increasing screening
services--mammography, pap, and human papillomavirus (HPV) tests--among
women. However, in 2021, approximately one quarter of adults were not
up to date with breast and/or cervical cancer screening, and screening
was underutilized among women who are under- or uninsured, have no
regular source of healthcare, or who recently immigrated to the U.S. As
a longstanding priority within chronic disease prevention, CDC focuses
on increasing access to these cancer screenings, particularly among
women who may be at increased risk.
To improve access to cancer screening, Congress passed the Breast
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 106-354),
which directed CDC to create the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP). The NBCCEDP currently provides
funding to 71 recipients under ``Cancer Prevention and Control Programs
for State, Territorial, and Tribal Organizations (DP22-2202).'' NBCCEDP
awardees include states or their bona fide agents; U.S. territories;
and tribes or tribal organizations. The purpose of NBCCEDP is to
increase breast and cervical cancer screening rates among women
residing within defined geographical locations (as determined by the
funded program) who are at or below 250% of the federal poverty level;
aged 50-75 years for breast cancer
[[Page 79923]]
services, and aged 21-64 years for cervical cancer services; and under-
or uninsured.
CDC proposes revisions to three of the previously approved
information collection instruments:
Annual NBCCEDP Survey--This instrument collects program-level
information annually to monitor recipients' challenges, external
funding sources, partnerships, and EBI implementation. The survey has
been revised to include new survey questions to improve data quality
for items related to partnership activities and recipients'
requirements for patients' payments towards screening services, as well
as the removal of a COVID-19 related question.
Clinic-Level Data Collection Tool--This instrument collects clinic-
level data at baseline and annually to assess health system, clinic,
and patient population characteristics; monitoring and quality
improvement activities; EBI implementation; and baseline or annual
screening rates. This tool has been revised to remove COVID-19 related
variables and update response options for the measures used to report
breast and cervical cancer screening rates.
QPU--This instrument collects program-level data four times per
year to monitor award spending, service delivery, staff vacancies,
program challenges and successes, and TA needs. This instrument has
been revised to include two optional open-ended items to allow
recipients to provide context to reported service delivery and spending
data only if needed.
CDC proposes continued use of the remaining two information
collections; Service Delivery Project Worksheet and the MDEs, which
have not been changed. To maximize consistency in our routine data
collections for the current NBCCEDP funding cycle, CDC has not revised
NBCCEDP information collections to align with the Department of Health
and Human Services (HHS)' current best practices for demographic
questions related to sexual orientation and gender identity (SOGI) and
race and ethnicity (R/E) at this time. However, CDC plans to revise
information collections that include demographic items to align with
HHS' SOGI and R/E guidelines for the next funding cycle beginning in
2027.
The proposed information collections will allow CDC to better gauge
progress in meeting NBCCEDP program goals and monitor implementation
activities, evaluate outcomes, and identify awardee technical
assistance needs. In addition, findings will inform program improvement
and help identify successful activities that need to be maintained,
replicated, or expanded.
OMB approval is requested for three years. CDC requests OMB
approval for an estimated 1,162 annual burden hours. Participation is
required for NBCCEDP awardees. There are no costs to respondents other
than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees.............. Annual NBCCEDP 71 1 46/60 54
Survey.
NBCCEDP Clinic- 71 6 40/60 284
level
Information
Collection
Instrument--Bre
ast.
NBCCEDP Clinic- 71 6 40/60 284
level
Information
Collection
Instrument--Cer
vical.
Quarterly 71 4 22/60 151
Program Update.
Service Delivery 71 1 29/60 34
Projection
Worksheet.
MDEs............ 71 2 150/60 355
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,162
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-22477 Filed 9-30-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 1, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.